Skip to main content

Published locations for mCRC: Triplet+bevacizumab offers survival advantage even in patients with bone metastasis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. mCRC: Triplet+bevacizumab offers survival advantage even in patients with bone metastasis

User login

  • Reset your password
  • /content/mcrc-tripletbevacizumab-offers-survival-advantage-even-patients-bone-metastasis
  • /hematology-oncology/article/259662/gastrointestinal-cancer/mcrc-tripletbevacizumab-offers-survival